Latest News of ALDX
Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory
By Yahoo! Finance |
2 months ago
Aldeyra Therapeutics is a biotech company focusing on innovative treatments for immune disorders like dry eye disease with its lead product, reproxalap. Despite setbacks, strategic partnerships and pi...
Owning 36% shares,institutional owners seem interested in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX),
By Yahoo! Finance |
3 months ago
Institutional investors hold a significant 36% stake in Aldeyra Therapeutics, influencing the company's direction. Insider ownership stands at 1.9%, while the general public and private equity firms h...